Ligand Pharmaceuticals, Inc. (LGND)
302.96
+0.22
(+0.07%)
USD |
NASDAQ |
Oct 02, 16:00
302.87
-0.09
(-0.03%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 6.035B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.035B |
| October 01, 2026 | 6.031B |
| September 30, 2026 | 6.222B |
| September 29, 2026 | 6.182B |
| September 28, 2026 | 6.257B |
| September 25, 2026 | 6.006B |
| September 24, 2026 | 5.957B |
| September 23, 2026 | 5.944B |
| September 22, 2026 | 5.946B |
| September 21, 2026 | 5.778B |
| September 18, 2026 | 5.647B |
| September 17, 2026 | 5.671B |
| September 16, 2026 | 5.482B |
| September 15, 2026 | 5.517B |
| September 14, 2026 | 5.591B |
| September 11, 2026 | 5.667B |
| September 10, 2026 | 5.762B |
| September 09, 2026 | 5.738B |
| September 08, 2026 | 5.753B |
| September 04, 2026 | 5.689B |
| September 03, 2026 | 5.772B |
| September 02, 2026 | 5.715B |
| September 01, 2026 | 5.663B |
| August 31, 2026 | 5.659B |
| August 28, 2026 | 5.587B |
| Date | Value |
|---|---|
| August 27, 2026 | 5.668B |
| August 26, 2026 | 5.734B |
| August 25, 2026 | 5.612B |
| August 24, 2026 | 5.581B |
| August 21, 2026 | 5.703B |
| August 20, 2026 | 5.725B |
| August 19, 2026 | 5.791B |
| August 18, 2026 | 5.729B |
| August 17, 2026 | 5.812B |
| August 14, 2026 | 5.868B |
| August 13, 2026 | 5.753B |
| August 12, 2026 | 5.842B |
| August 11, 2026 | 5.752B |
| August 10, 2026 | 5.890B |
| August 07, 2026 | 5.840B |
| August 06, 2026 | 5.979B |
| August 05, 2026 | 6.027B |
| August 04, 2026 | 6.025B |
| August 03, 2026 | 5.849B |
| July 31, 2026 | 5.759B |
| July 30, 2026 | 5.934B |
| July 29, 2026 | 5.769B |
| July 28, 2026 | 5.934B |
| July 27, 2026 | 5.959B |
| July 24, 2026 | 6.019B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 616.58B |
| Eli Lilly & Co. | 1.076T |
| Merck & Co., Inc. | 356.23B |
| Zevra Therapeutics, Inc. | 592.83M |
| Liquidia Corp. | 2.552B |
Market Cap Related Metrics
| PE Ratio | 32.39 |
| PS Ratio | 21.76 |
| Price to Book Value | 6.238 |
| Price to Free Cash Flow | 52.77 |
| Price | 302.96 |
| Earnings Yield | 3.09% |
| Operating PE Ratio | 63.17 |
| Normalized PE Ratio | 43.05 |